VYDURA ODT cpr orodisp 75 mg 16 pce
7680690350031
CH-69035
N02CD06
02.05.1.
Reimbursement limitations:
VYDURA2.01
Le traitement nécessite la garantie de prise en charge des coûts par l’assurance maladie après …
1 / 3
google
Details
- Product number
- 6903501
- CPT
- -
- Packaging group
- 16
- Unit
- Einzeldose(n)
- Composition
- rimegepantum 75 mg ut rimegepanti hemisulfas sesquihydricus, gelatina, mannitolum, sucralosum, aromatica (Minze) cum alcohol benzylicus, pro compresso.
Articles (1)
Vydura 75 mg, Lyophilisat zum Einnehmen
Lyophilisat
16
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
75.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | AROMA |
|
(N/A)
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 412.00
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/05/2024
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 69035
- Drug name
- Vydura, Lyophilisat zum Einnehmen
- Galenic form
- LYO
- ATC Code
- N02CD06
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 18/10/2023
- Authorization expiration date
- 17/10/2028
- IT number
- 02.05.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VYDURA ODT cpr orodisp 75 mg 16 pce
- Description (DE)
- VYDURA ODT Schmelztabl 75 mg 16 Stk
- Market launch
- 18/10/2023
- Narcotic (BTM)
- No